English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Jun 8, 2026

Researchers identify immune pathway as potential target for Huntington disease therapy

Patient Daily | Jun 8, 2026

Online tool shows high satisfaction among cancer trial participants, study finds

Patient Daily | Jun 8, 2026

RevMed and Tango report 92% response rate in pancreatic cancer drug combination trial

Patient Daily | Jun 8, 2026

FDA introduces new pathways for rare disease drug development, raising questions among experts

Patient Daily | Jun 8, 2026

Roche announces up to $3 billion deal with Nurix for blood cancer drug development

Patient Daily | Jun 8, 2026

Survey finds many Americans unaware of diet's impact on cholesterol levels

Patient Daily | Jun 8, 2026

Researchers study impact of paternal alcohol use on child development and health

Patient Daily | Jun 8, 2026

Paris medics use handheld tech and AR to boost cardiac arrest survival rates

Trending

Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families

+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’

+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions

+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures

  • « First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily